Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G49108TO
Summary
- GlyTouCan ID
-
G49108TO
- IUPAC Condensed
- GlcNAc(b1-
External Links
- GlyConnect structure
- GlyGen
- ChEBI
- PubChem Compound
- PubChem Substance
- The Human Metabolome Database
- CarbBank
- 9 3780 3968 4708 25653 28493 29021 29527 29549 31775 32028 32903 33539 36048 36270 37035 37525 37675 37677 37678 39452 39454 39456 39609 39611 39613 39614 40149 40150 40151 40355 40591 40600 42059 42207 42220 43184 43893 43925 43926 43931 43932 43941 44395 44396 44397 44549 46453 47268 47468 47537 47603 47796 48630 48812 48813 49006 49732 50589 50736
3D Structures
- GLYCAM
- DGlcpNAcb1-OH
G14843DJ
G68544GH
Organisms
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
G49108TO
|
R |
G00055MO
|
R | |
| B4GALT2 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B3GALT5 | UDP-Gal |
G49108TO
|
R |
G00056MO
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALNT3 | UDP-GalNAc |
G49108TO
|
[beta]-Bz |
G00057MO
|
[beta]-Bz | |
| B3GALNT2 | UDP-GalNAc |
G49108TO
|
[beta]-Bz |
G36387CV
|
[beta]-Bz | |
| B4GALNT4 | UDP-GalNAc |
G49108TO
|
[beta]-Bz |
G00057MO
|
[beta]-Bz | |
| B3GALNT2 | UDP-GalNAc |
G49108TO
|
R |
G36387CV
|
R | |
| B4GALT1 | UDP-Glc |
G49108TO
|
R |
G38884XS
|
R |
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q9HCM2 | Plexin-A4 | ||
| Q9HCM7 | Fibrosin-1-like protein | ||
| Q9HCM9 | E3 ubiquitin-protein ligase TRIM39 | ||
| Q9HCN8 | Stromal cell-derived factor 2-like protein 1 | ||
| Q9HCR9 | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | ||
| Q9HCS2 | Cytochrome P450 4F12 | ||
| Q9HCS5 | Band 4.1-like protein 4A | ||
| Q9HCU4 | Cadherin EGF LAG seven-pass G-type receptor 2 | ||
| Q9HD15 | Steroid receptor RNA activator 1 | ||
| Q9HD20 | Endoplasmic reticulum transmembrane helix translocase |
GlycoEpitope
- Epitope ID
- EP0004
Pathway
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2122h-1b_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 36809668 | X‐ray structure and function of fibronectin domains two and three of the neural cell adhesion molecule <scp>L1</scp> | Guédez G | 2023 Feb 21 |
|
| 36808582 | Evaluation of the interaction between potent small molecules against the Nipah virus Glycoprotein in Malaysia and Bangladesh strains, accompanied by the human Ephrin-B2 and Ephrin-B3 receptors; a simulation approach | Ebrahimi M | 2023 Feb 20 |
|
| 36802545 | Combining Selective Enrichment and a Boosting Approach to Globally and Site-Specifically Characterize Protein Co-translational O-GlcNAcylation | Xu S | 2023 Feb 20 |
|
| 36797290 | Native structure of mosquito salivary protein uncovers domains relevant to pathogen transmission | Liu S | 2023 Feb 17 |
|
| 36797531 | Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | Liu C | 2023 Feb 17 |
|
| 36788293 | Origins and immunopathogenesis of autoimmune central nervous system disorders | Ramanathan S | 2023 Feb 14 |
|
| 36781872 | Cross-protective antibodies against common endemic respiratory viruses | Cabán M | 2023 Feb 13 |
|
| 36779874 | Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain Model | Harris LD | 2023 Feb 13 |
|
| 36765030 | O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner | Yang Y | 2023 Feb 10 |
|
| 36762932 | Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity | Karade SS | 2023 Feb 10 |
|
